nodes	percent_of_prediction	percent_of_DWPC	metapath
Azilsartan medoxomil—Olmesartan—ABCC2—epilepsy syndrome	0.00328	0.206	CrCbGaD
Azilsartan medoxomil—Telmisartan—ABCC2—epilepsy syndrome	0.00317	0.199	CrCbGaD
Azilsartan medoxomil—Telmisartan—ABCG2—epilepsy syndrome	0.0028	0.176	CrCbGaD
Azilsartan medoxomil—Unspecified disorder of skin and subcutaneous tissue—Levetiracetam—epilepsy syndrome	0.00224	0.00389	CcSEcCtD
Azilsartan medoxomil—Muscle spasms—Zonisamide—epilepsy syndrome	0.00224	0.00388	CcSEcCtD
Azilsartan medoxomil—Angiopathy—Carbamazepine—epilepsy syndrome	0.00222	0.00384	CcSEcCtD
Azilsartan medoxomil—Telmisartan—CYP2C19—epilepsy syndrome	0.0022	0.138	CrCbGaD
Azilsartan medoxomil—Muscle spasms—Clonazepam—epilepsy syndrome	0.00216	0.00374	CcSEcCtD
Azilsartan medoxomil—Rash—Trimethadione—epilepsy syndrome	0.00216	0.00374	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Trimethadione—epilepsy syndrome	0.00215	0.00373	CcSEcCtD
Azilsartan medoxomil—Nervous system disorder—Midazolam—epilepsy syndrome	0.00215	0.00373	CcSEcCtD
Azilsartan medoxomil—Angiopathy—Lamotrigine—epilepsy syndrome	0.00214	0.00372	CcSEcCtD
Azilsartan medoxomil—Muscle spasms—Phenytoin—epilepsy syndrome	0.00214	0.00371	CcSEcCtD
Azilsartan medoxomil—Asthenia—Rufinamide—epilepsy syndrome	0.00213	0.0037	CcSEcCtD
Azilsartan medoxomil—Skin disorder—Midazolam—epilepsy syndrome	0.00213	0.00369	CcSEcCtD
Azilsartan medoxomil—Nervous system disorder—Levetiracetam—epilepsy syndrome	0.00212	0.00368	CcSEcCtD
Azilsartan medoxomil—Unspecified disorder of skin and subcutaneous tissue—Vigabatrin—epilepsy syndrome	0.00211	0.00366	CcSEcCtD
Azilsartan medoxomil—Blood creatinine increased—Gabapentin—epilepsy syndrome	0.00211	0.00365	CcSEcCtD
Azilsartan medoxomil—Skin disorder—Levetiracetam—epilepsy syndrome	0.0021	0.00365	CcSEcCtD
Azilsartan medoxomil—Pruritus—Rufinamide—epilepsy syndrome	0.0021	0.00364	CcSEcCtD
Azilsartan medoxomil—Gastrointestinal disorder—Acetazolamide—epilepsy syndrome	0.00208	0.00361	CcSEcCtD
Azilsartan medoxomil—Fatigue—Acetazolamide—epilepsy syndrome	0.00208	0.00361	CcSEcCtD
Azilsartan medoxomil—Unspecified disorder of skin and subcutaneous tissue—Diazepam—epilepsy syndrome	0.00208	0.0036	CcSEcCtD
Azilsartan medoxomil—Angioedema—Clonazepam—epilepsy syndrome	0.00205	0.00355	CcSEcCtD
Azilsartan medoxomil—Muscle spasms—Carbamazepine—epilepsy syndrome	0.00205	0.00355	CcSEcCtD
Azilsartan medoxomil—Diarrhoea—Rufinamide—epilepsy syndrome	0.00203	0.00352	CcSEcCtD
Azilsartan medoxomil—Nausea—Trimethadione—epilepsy syndrome	0.00203	0.00352	CcSEcCtD
Azilsartan medoxomil—Angioedema—Oxcarbazepine—epilepsy syndrome	0.00203	0.00351	CcSEcCtD
Azilsartan medoxomil—Asthenia—Lacosamide—epilepsy syndrome	0.002	0.00347	CcSEcCtD
Azilsartan medoxomil—Dizziness—Phenobarbital—epilepsy syndrome	0.002	0.00347	CcSEcCtD
Azilsartan medoxomil—Nervous system disorder—Vigabatrin—epilepsy syndrome	0.002	0.00346	CcSEcCtD
Azilsartan medoxomil—Skin disorder—Vigabatrin—epilepsy syndrome	0.00198	0.00343	CcSEcCtD
Azilsartan medoxomil—Muscle spasms—Lamotrigine—epilepsy syndrome	0.00198	0.00343	CcSEcCtD
Azilsartan medoxomil—Pruritus—Lacosamide—epilepsy syndrome	0.00197	0.00342	CcSEcCtD
Azilsartan medoxomil—Unspecified disorder of skin and subcutaneous tissue—Zonisamide—epilepsy syndrome	0.00197	0.00341	CcSEcCtD
Azilsartan medoxomil—Nervous system disorder—Diazepam—epilepsy syndrome	0.00197	0.00341	CcSEcCtD
Azilsartan medoxomil—Dizziness—Rufinamide—epilepsy syndrome	0.00196	0.00341	CcSEcCtD
Azilsartan medoxomil—Skin disorder—Diazepam—epilepsy syndrome	0.00195	0.00338	CcSEcCtD
Azilsartan medoxomil—Angioedema—Carbamazepine—epilepsy syndrome	0.00194	0.00337	CcSEcCtD
Azilsartan medoxomil—Asthenia—Clobazam—epilepsy syndrome	0.00194	0.00337	CcSEcCtD
Azilsartan medoxomil—Fatigue—Propofol—epilepsy syndrome	0.00193	0.00335	CcSEcCtD
Azilsartan medoxomil—Pruritus—Clobazam—epilepsy syndrome	0.00192	0.00332	CcSEcCtD
Azilsartan medoxomil—Diarrhoea—Lacosamide—epilepsy syndrome	0.00191	0.00331	CcSEcCtD
Azilsartan medoxomil—Rash—Phenobarbital—epilepsy syndrome	0.00191	0.00331	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Phenobarbital—epilepsy syndrome	0.00191	0.00331	CcSEcCtD
Azilsartan medoxomil—Unspecified disorder of skin and subcutaneous tissue—Clonazepam—epilepsy syndrome	0.0019	0.00329	CcSEcCtD
Azilsartan medoxomil—Gastrointestinal disorder—Midazolam—epilepsy syndrome	0.00189	0.00328	CcSEcCtD
Azilsartan medoxomil—Fatigue—Midazolam—epilepsy syndrome	0.00189	0.00328	CcSEcCtD
Azilsartan medoxomil—Angioedema—Lamotrigine—epilepsy syndrome	0.00188	0.00326	CcSEcCtD
Azilsartan medoxomil—Unspecified disorder of skin and subcutaneous tissue—Oxcarbazepine—epilepsy syndrome	0.00187	0.00325	CcSEcCtD
Azilsartan medoxomil—Rash—Rufinamide—epilepsy syndrome	0.00187	0.00325	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Rufinamide—epilepsy syndrome	0.00187	0.00324	CcSEcCtD
Azilsartan medoxomil—Gastrointestinal disorder—Levetiracetam—epilepsy syndrome	0.00187	0.00324	CcSEcCtD
Azilsartan medoxomil—Fatigue—Levetiracetam—epilepsy syndrome	0.00187	0.00324	CcSEcCtD
Azilsartan medoxomil—Nervous system disorder—Zonisamide—epilepsy syndrome	0.00186	0.00323	CcSEcCtD
Azilsartan medoxomil—Diarrhoea—Clobazam—epilepsy syndrome	0.00185	0.00321	CcSEcCtD
Azilsartan medoxomil—Oedema peripheral—Valproic Acid—epilepsy syndrome	0.00185	0.00321	CcSEcCtD
Azilsartan medoxomil—Skin disorder—Zonisamide—epilepsy syndrome	0.00185	0.0032	CcSEcCtD
Azilsartan medoxomil—Dizziness—Lacosamide—epilepsy syndrome	0.00184	0.0032	CcSEcCtD
Azilsartan medoxomil—Connective tissue disorder—Valproic Acid—epilepsy syndrome	0.00184	0.0032	CcSEcCtD
Azilsartan medoxomil—Unspecified disorder of skin and subcutaneous tissue—Carbamazepine—epilepsy syndrome	0.0018	0.00312	CcSEcCtD
Azilsartan medoxomil—Nausea—Phenobarbital—epilepsy syndrome	0.0018	0.00312	CcSEcCtD
Azilsartan medoxomil—Nervous system disorder—Clonazepam—epilepsy syndrome	0.0018	0.00311	CcSEcCtD
Azilsartan medoxomil—Dizziness—Clobazam—epilepsy syndrome	0.00179	0.0031	CcSEcCtD
Azilsartan medoxomil—Nervous system disorder—Phenytoin—epilepsy syndrome	0.00178	0.00309	CcSEcCtD
Azilsartan medoxomil—Skin disorder—Clonazepam—epilepsy syndrome	0.00178	0.00308	CcSEcCtD
Azilsartan medoxomil—Nervous system disorder—Oxcarbazepine—epilepsy syndrome	0.00177	0.00308	CcSEcCtD
Azilsartan medoxomil—Blood creatinine increased—Topiramate—epilepsy syndrome	0.00177	0.00307	CcSEcCtD
Azilsartan medoxomil—Nausea—Rufinamide—epilepsy syndrome	0.00176	0.00306	CcSEcCtD
Azilsartan medoxomil—Rash—Lacosamide—epilepsy syndrome	0.00176	0.00305	CcSEcCtD
Azilsartan medoxomil—Gastrointestinal disorder—Vigabatrin—epilepsy syndrome	0.00176	0.00305	CcSEcCtD
Azilsartan medoxomil—Skin disorder—Oxcarbazepine—epilepsy syndrome	0.00176	0.00305	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Lacosamide—epilepsy syndrome	0.00176	0.00305	CcSEcCtD
Azilsartan medoxomil—Fatigue—Vigabatrin—epilepsy syndrome	0.00176	0.00304	CcSEcCtD
Azilsartan medoxomil—Gastrointestinal disorder—Diazepam—epilepsy syndrome	0.00173	0.003	CcSEcCtD
Azilsartan medoxomil—Asthenia—Acetazolamide—epilepsy syndrome	0.00173	0.003	CcSEcCtD
Azilsartan medoxomil—Fatigue—Diazepam—epilepsy syndrome	0.00173	0.003	CcSEcCtD
Azilsartan medoxomil—Rash—Clobazam—epilepsy syndrome	0.00171	0.00296	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Clobazam—epilepsy syndrome	0.00171	0.00296	CcSEcCtD
Azilsartan medoxomil—Angiopathy—Valproic Acid—epilepsy syndrome	0.0017	0.00295	CcSEcCtD
Azilsartan medoxomil—Nervous system disorder—Carbamazepine—epilepsy syndrome	0.0017	0.00295	CcSEcCtD
Azilsartan medoxomil—Skin disorder—Carbamazepine—epilepsy syndrome	0.00169	0.00292	CcSEcCtD
Azilsartan medoxomil—Fatigue—Felbamate—epilepsy syndrome	0.00167	0.0029	CcSEcCtD
Azilsartan medoxomil—Oedema peripheral—Pregabalin—epilepsy syndrome	0.00167	0.0029	CcSEcCtD
Azilsartan medoxomil—Connective tissue disorder—Pregabalin—epilepsy syndrome	0.00167	0.00289	CcSEcCtD
Azilsartan medoxomil—Nausea—Lacosamide—epilepsy syndrome	0.00166	0.00287	CcSEcCtD
Azilsartan medoxomil—Diarrhoea—Acetazolamide—epilepsy syndrome	0.00165	0.00286	CcSEcCtD
Azilsartan medoxomil—Nervous system disorder—Lamotrigine—epilepsy syndrome	0.00165	0.00285	CcSEcCtD
Azilsartan medoxomil—Gastrointestinal disorder—Zonisamide—epilepsy syndrome	0.00164	0.00284	CcSEcCtD
Azilsartan medoxomil—Fatigue—Zonisamide—epilepsy syndrome	0.00164	0.00284	CcSEcCtD
Azilsartan medoxomil—Nausea—Clobazam—epilepsy syndrome	0.00161	0.00279	CcSEcCtD
Azilsartan medoxomil—Asthenia—Propofol—epilepsy syndrome	0.00161	0.00279	CcSEcCtD
Azilsartan medoxomil—Dizziness—Acetazolamide—epilepsy syndrome	0.0016	0.00277	CcSEcCtD
Azilsartan medoxomil—Pruritus—Propofol—epilepsy syndrome	0.00159	0.00275	CcSEcCtD
Azilsartan medoxomil—Gastrointestinal disorder—Clonazepam—epilepsy syndrome	0.00158	0.00274	CcSEcCtD
Azilsartan medoxomil—Fatigue—Clonazepam—epilepsy syndrome	0.00158	0.00274	CcSEcCtD
Azilsartan medoxomil—Asthenia—Midazolam—epilepsy syndrome	0.00157	0.00273	CcSEcCtD
Azilsartan medoxomil—Muscle spasms—Valproic Acid—epilepsy syndrome	0.00157	0.00272	CcSEcCtD
Azilsartan medoxomil—Gastrointestinal disorder—Phenytoin—epilepsy syndrome	0.00157	0.00272	CcSEcCtD
Azilsartan medoxomil—Fatigue—Phenytoin—epilepsy syndrome	0.00157	0.00272	CcSEcCtD
Azilsartan medoxomil—Gastrointestinal disorder—Oxcarbazepine—epilepsy syndrome	0.00156	0.00271	CcSEcCtD
Azilsartan medoxomil—Fatigue—Oxcarbazepine—epilepsy syndrome	0.00156	0.0027	CcSEcCtD
Azilsartan medoxomil—Asthenia—Levetiracetam—epilepsy syndrome	0.00155	0.00269	CcSEcCtD
Azilsartan medoxomil—Pruritus—Midazolam—epilepsy syndrome	0.00155	0.00269	CcSEcCtD
Azilsartan medoxomil—Angiopathy—Pregabalin—epilepsy syndrome	0.00154	0.00267	CcSEcCtD
Azilsartan medoxomil—Diarrhoea—Propofol—epilepsy syndrome	0.00153	0.00266	CcSEcCtD
Azilsartan medoxomil—Oedema peripheral—Gabapentin—epilepsy syndrome	0.00153	0.00266	CcSEcCtD
Azilsartan medoxomil—Pruritus—Levetiracetam—epilepsy syndrome	0.00153	0.00266	CcSEcCtD
Azilsartan medoxomil—Connective tissue disorder—Gabapentin—epilepsy syndrome	0.00153	0.00265	CcSEcCtD
Azilsartan medoxomil—Asthenia—Fosphenytoin—epilepsy syndrome	0.0015	0.0026	CcSEcCtD
Azilsartan medoxomil—Gastrointestinal disorder—Carbamazepine—epilepsy syndrome	0.0015	0.0026	CcSEcCtD
Azilsartan medoxomil—Fatigue—Carbamazepine—epilepsy syndrome	0.0015	0.0026	CcSEcCtD
Azilsartan medoxomil—Angioedema—Valproic Acid—epilepsy syndrome	0.00149	0.00259	CcSEcCtD
Azilsartan medoxomil—Dizziness—Propofol—epilepsy syndrome	0.00148	0.00257	CcSEcCtD
Azilsartan medoxomil—Diarrhoea—Levetiracetam—epilepsy syndrome	0.00148	0.00257	CcSEcCtD
Azilsartan medoxomil—Pruritus—Fosphenytoin—epilepsy syndrome	0.00148	0.00256	CcSEcCtD
Azilsartan medoxomil—Asthenia—Vigabatrin—epilepsy syndrome	0.00146	0.00253	CcSEcCtD
Azilsartan medoxomil—Dizziness—Midazolam—epilepsy syndrome	0.00145	0.00251	CcSEcCtD
Azilsartan medoxomil—Gastrointestinal disorder—Lamotrigine—epilepsy syndrome	0.00145	0.00251	CcSEcCtD
Azilsartan medoxomil—Fatigue—Lamotrigine—epilepsy syndrome	0.00145	0.00251	CcSEcCtD
Azilsartan medoxomil—Pruritus—Vigabatrin—epilepsy syndrome	0.00144	0.0025	CcSEcCtD
Azilsartan medoxomil—Asthenia—Diazepam—epilepsy syndrome	0.00144	0.00249	CcSEcCtD
Azilsartan medoxomil—Nausea—Acetazolamide—epilepsy syndrome	0.00143	0.00248	CcSEcCtD
Azilsartan medoxomil—Dizziness—Levetiracetam—epilepsy syndrome	0.00143	0.00248	CcSEcCtD
Azilsartan medoxomil—Diarrhoea—Fosphenytoin—epilepsy syndrome	0.00143	0.00248	CcSEcCtD
Azilsartan medoxomil—Muscle spasms—Pregabalin—epilepsy syndrome	0.00142	0.00246	CcSEcCtD
Azilsartan medoxomil—Pruritus—Diazepam—epilepsy syndrome	0.00142	0.00246	CcSEcCtD
Azilsartan medoxomil—Rash—Propofol—epilepsy syndrome	0.00141	0.00245	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Propofol—epilepsy syndrome	0.00141	0.00245	CcSEcCtD
Azilsartan medoxomil—Diarrhoea—Vigabatrin—epilepsy syndrome	0.00139	0.00242	CcSEcCtD
Azilsartan medoxomil—Asthenia—Felbamate—epilepsy syndrome	0.00139	0.00241	CcSEcCtD
Azilsartan medoxomil—Rash—Midazolam—epilepsy syndrome	0.00138	0.0024	CcSEcCtD
Azilsartan medoxomil—Dizziness—Fosphenytoin—epilepsy syndrome	0.00138	0.0024	CcSEcCtD
Azilsartan medoxomil—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—epilepsy syndrome	0.00138	0.00239	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Midazolam—epilepsy syndrome	0.00138	0.00239	CcSEcCtD
Azilsartan medoxomil—Pruritus—Felbamate—epilepsy syndrome	0.00137	0.00238	CcSEcCtD
Azilsartan medoxomil—Diarrhoea—Diazepam—epilepsy syndrome	0.00137	0.00238	CcSEcCtD
Azilsartan medoxomil—Rash—Levetiracetam—epilepsy syndrome	0.00137	0.00237	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Levetiracetam—epilepsy syndrome	0.00136	0.00236	CcSEcCtD
Azilsartan medoxomil—Asthenia—Zonisamide—epilepsy syndrome	0.00136	0.00236	CcSEcCtD
Azilsartan medoxomil—Angioedema—Pregabalin—epilepsy syndrome	0.00135	0.00234	CcSEcCtD
Azilsartan medoxomil—Dizziness—Vigabatrin—epilepsy syndrome	0.00135	0.00234	CcSEcCtD
Azilsartan medoxomil—Pruritus—Zonisamide—epilepsy syndrome	0.00134	0.00233	CcSEcCtD
Azilsartan medoxomil—Nausea—Propofol—epilepsy syndrome	0.00133	0.00231	CcSEcCtD
Azilsartan medoxomil—Diarrhoea—Felbamate—epilepsy syndrome	0.00133	0.0023	CcSEcCtD
Azilsartan medoxomil—Dizziness—Diazepam—epilepsy syndrome	0.00133	0.0023	CcSEcCtD
Azilsartan medoxomil—Rash—Fosphenytoin—epilepsy syndrome	0.00132	0.00228	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Fosphenytoin—epilepsy syndrome	0.00132	0.00228	CcSEcCtD
Azilsartan medoxomil—Asthenia—Clonazepam—epilepsy syndrome	0.00131	0.00228	CcSEcCtD
Azilsartan medoxomil—Nervous system disorder—Valproic Acid—epilepsy syndrome	0.00131	0.00227	CcSEcCtD
Azilsartan medoxomil—Asthenia—Phenytoin—epilepsy syndrome	0.00131	0.00226	CcSEcCtD
Azilsartan medoxomil—Nausea—Midazolam—epilepsy syndrome	0.0013	0.00226	CcSEcCtD
Azilsartan medoxomil—Muscle spasms—Gabapentin—epilepsy syndrome	0.0013	0.00226	CcSEcCtD
Azilsartan medoxomil—Diarrhoea—Zonisamide—epilepsy syndrome	0.0013	0.00225	CcSEcCtD
Azilsartan medoxomil—Asthenia—Oxcarbazepine—epilepsy syndrome	0.0013	0.00225	CcSEcCtD
Azilsartan medoxomil—Pruritus—Clonazepam—epilepsy syndrome	0.0013	0.00225	CcSEcCtD
Azilsartan medoxomil—Skin disorder—Valproic Acid—epilepsy syndrome	0.0013	0.00225	CcSEcCtD
Azilsartan medoxomil—Oedema peripheral—Topiramate—epilepsy syndrome	0.00129	0.00224	CcSEcCtD
Azilsartan medoxomil—Pruritus—Phenytoin—epilepsy syndrome	0.00129	0.00223	CcSEcCtD
Azilsartan medoxomil—Connective tissue disorder—Topiramate—epilepsy syndrome	0.00129	0.00223	CcSEcCtD
Azilsartan medoxomil—Nausea—Levetiracetam—epilepsy syndrome	0.00129	0.00223	CcSEcCtD
Azilsartan medoxomil—Rash—Vigabatrin—epilepsy syndrome	0.00128	0.00223	CcSEcCtD
Azilsartan medoxomil—Dizziness—Felbamate—epilepsy syndrome	0.00128	0.00223	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Vigabatrin—epilepsy syndrome	0.00128	0.00222	CcSEcCtD
Azilsartan medoxomil—Pruritus—Oxcarbazepine—epilepsy syndrome	0.00128	0.00222	CcSEcCtD
Azilsartan medoxomil—Rash—Diazepam—epilepsy syndrome	0.00126	0.00219	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Diazepam—epilepsy syndrome	0.00126	0.00219	CcSEcCtD
Azilsartan medoxomil—Dizziness—Zonisamide—epilepsy syndrome	0.00126	0.00218	CcSEcCtD
Azilsartan medoxomil—Diarrhoea—Clonazepam—epilepsy syndrome	0.00125	0.00217	CcSEcCtD
Azilsartan medoxomil—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	0.00125	0.00217	CcSEcCtD
Azilsartan medoxomil—Asthenia—Carbamazepine—epilepsy syndrome	0.00125	0.00216	CcSEcCtD
Azilsartan medoxomil—Diarrhoea—Phenytoin—epilepsy syndrome	0.00124	0.00216	CcSEcCtD
Azilsartan medoxomil—Nausea—Fosphenytoin—epilepsy syndrome	0.00124	0.00215	CcSEcCtD
Azilsartan medoxomil—Diarrhoea—Oxcarbazepine—epilepsy syndrome	0.00124	0.00215	CcSEcCtD
Azilsartan medoxomil—Angioedema—Gabapentin—epilepsy syndrome	0.00124	0.00215	CcSEcCtD
Azilsartan medoxomil—Pruritus—Carbamazepine—epilepsy syndrome	0.00123	0.00213	CcSEcCtD
Azilsartan medoxomil—Rash—Felbamate—epilepsy syndrome	0.00122	0.00212	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Felbamate—epilepsy syndrome	0.00122	0.00212	CcSEcCtD
Azilsartan medoxomil—Dizziness—Clonazepam—epilepsy syndrome	0.00121	0.0021	CcSEcCtD
Azilsartan medoxomil—Nausea—Vigabatrin—epilepsy syndrome	0.00121	0.0021	CcSEcCtD
Azilsartan medoxomil—Asthenia—Lamotrigine—epilepsy syndrome	0.0012	0.00209	CcSEcCtD
Azilsartan medoxomil—Dizziness—Phenytoin—epilepsy syndrome	0.0012	0.00209	CcSEcCtD
Azilsartan medoxomil—Rash—Zonisamide—epilepsy syndrome	0.0012	0.00208	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Zonisamide—epilepsy syndrome	0.0012	0.00208	CcSEcCtD
Azilsartan medoxomil—Dizziness—Oxcarbazepine—epilepsy syndrome	0.0012	0.00207	CcSEcCtD
Azilsartan medoxomil—Nausea—Diazepam—epilepsy syndrome	0.00119	0.00207	CcSEcCtD
Azilsartan medoxomil—Diarrhoea—Carbamazepine—epilepsy syndrome	0.00119	0.00206	CcSEcCtD
Azilsartan medoxomil—Angiopathy—Topiramate—epilepsy syndrome	0.00119	0.00206	CcSEcCtD
Azilsartan medoxomil—Pruritus—Lamotrigine—epilepsy syndrome	0.00119	0.00206	CcSEcCtD
Azilsartan medoxomil—Nervous system disorder—Pregabalin—epilepsy syndrome	0.00118	0.00205	CcSEcCtD
Azilsartan medoxomil—Skin disorder—Pregabalin—epilepsy syndrome	0.00117	0.00203	CcSEcCtD
Azilsartan medoxomil—Telmisartan—ABCB1—epilepsy syndrome	0.00117	0.0731	CrCbGaD
Azilsartan medoxomil—Rash—Clonazepam—epilepsy syndrome	0.00115	0.002	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Clonazepam—epilepsy syndrome	0.00115	0.002	CcSEcCtD
Azilsartan medoxomil—Nausea—Felbamate—epilepsy syndrome	0.00115	0.002	CcSEcCtD
Azilsartan medoxomil—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	0.00115	0.002	CcSEcCtD
Azilsartan medoxomil—Fatigue—Valproic Acid—epilepsy syndrome	0.00115	0.00199	CcSEcCtD
Azilsartan medoxomil—Dizziness—Carbamazepine—epilepsy syndrome	0.00115	0.00199	CcSEcCtD
Azilsartan medoxomil—Diarrhoea—Lamotrigine—epilepsy syndrome	0.00115	0.00199	CcSEcCtD
Azilsartan medoxomil—Rash—Phenytoin—epilepsy syndrome	0.00115	0.00199	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Phenytoin—epilepsy syndrome	0.00115	0.00199	CcSEcCtD
Azilsartan medoxomil—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	0.00115	0.00199	CcSEcCtD
Azilsartan medoxomil—Losartan—CYP2C19—epilepsy syndrome	0.00114	0.0717	CrCbGaD
Azilsartan medoxomil—Rash—Oxcarbazepine—epilepsy syndrome	0.00114	0.00198	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Oxcarbazepine—epilepsy syndrome	0.00114	0.00198	CcSEcCtD
Azilsartan medoxomil—Nausea—Zonisamide—epilepsy syndrome	0.00113	0.00196	CcSEcCtD
Azilsartan medoxomil—Dizziness—Lamotrigine—epilepsy syndrome	0.00111	0.00192	CcSEcCtD
Azilsartan medoxomil—Muscle spasms—Topiramate—epilepsy syndrome	0.0011	0.0019	CcSEcCtD
Azilsartan medoxomil—Rash—Carbamazepine—epilepsy syndrome	0.00109	0.0019	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Carbamazepine—epilepsy syndrome	0.00109	0.0019	CcSEcCtD
Azilsartan medoxomil—Nausea—Clonazepam—epilepsy syndrome	0.00109	0.00189	CcSEcCtD
Azilsartan medoxomil—Nervous system disorder—Gabapentin—epilepsy syndrome	0.00108	0.00188	CcSEcCtD
Azilsartan medoxomil—Nausea—Phenytoin—epilepsy syndrome	0.00108	0.00187	CcSEcCtD
Azilsartan medoxomil—Nausea—Oxcarbazepine—epilepsy syndrome	0.00107	0.00186	CcSEcCtD
Azilsartan medoxomil—Skin disorder—Gabapentin—epilepsy syndrome	0.00107	0.00186	CcSEcCtD
Azilsartan medoxomil—Rash—Lamotrigine—epilepsy syndrome	0.00106	0.00183	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Lamotrigine—epilepsy syndrome	0.00106	0.00183	CcSEcCtD
Azilsartan medoxomil—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	0.00104	0.0018	CcSEcCtD
Azilsartan medoxomil—Fatigue—Pregabalin—epilepsy syndrome	0.00104	0.0018	CcSEcCtD
Azilsartan medoxomil—Nausea—Carbamazepine—epilepsy syndrome	0.00103	0.00179	CcSEcCtD
Azilsartan medoxomil—Nausea—Lamotrigine—epilepsy syndrome	0.000997	0.00173	CcSEcCtD
Azilsartan medoxomil—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	0.000964	0.00167	CcSEcCtD
Azilsartan medoxomil—Asthenia—Valproic Acid—epilepsy syndrome	0.000957	0.00166	CcSEcCtD
Azilsartan medoxomil—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	0.000954	0.00165	CcSEcCtD
Azilsartan medoxomil—Fatigue—Gabapentin—epilepsy syndrome	0.000953	0.00165	CcSEcCtD
Azilsartan medoxomil—Pruritus—Valproic Acid—epilepsy syndrome	0.000943	0.00164	CcSEcCtD
Azilsartan medoxomil—Candesartan—ABCB1—epilepsy syndrome	0.000939	0.0589	CrCbGaD
Azilsartan medoxomil—Diarrhoea—Valproic Acid—epilepsy syndrome	0.000912	0.00158	CcSEcCtD
Azilsartan medoxomil—Nervous system disorder—Topiramate—epilepsy syndrome	0.000912	0.00158	CcSEcCtD
Azilsartan medoxomil—Skin disorder—Topiramate—epilepsy syndrome	0.000903	0.00157	CcSEcCtD
Azilsartan medoxomil—Dizziness—Valproic Acid—epilepsy syndrome	0.000882	0.00153	CcSEcCtD
Azilsartan medoxomil—Asthenia—Pregabalin—epilepsy syndrome	0.000865	0.0015	CcSEcCtD
Azilsartan medoxomil—Pruritus—Pregabalin—epilepsy syndrome	0.000853	0.00148	CcSEcCtD
Azilsartan medoxomil—Rash—Valproic Acid—epilepsy syndrome	0.000841	0.00146	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Valproic Acid—epilepsy syndrome	0.00084	0.00146	CcSEcCtD
Azilsartan medoxomil—Diarrhoea—Pregabalin—epilepsy syndrome	0.000825	0.00143	CcSEcCtD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—CX3CR1—epilepsy syndrome	0.000821	0.00202	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCRs, Class A Rhodopsin-like—HTR7—epilepsy syndrome	0.000819	0.00201	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—CCR10—epilepsy syndrome	0.000808	0.00198	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—BDKRB1—epilepsy syndrome	0.000805	0.00198	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—CHRM2—epilepsy syndrome	0.000805	0.00198	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—CX3CL1—epilepsy syndrome	0.000805	0.00198	CbGpPWpGaD
Azilsartan medoxomil—Gastrointestinal disorder—Topiramate—epilepsy syndrome	0.000803	0.00139	CcSEcCtD
Azilsartan medoxomil—Fatigue—Topiramate—epilepsy syndrome	0.000802	0.00139	CcSEcCtD
Azilsartan medoxomil—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—epilepsy syndrome	0.000798	0.00196	CbGpPWpGaD
Azilsartan medoxomil—Dizziness—Pregabalin—epilepsy syndrome	0.000797	0.00138	CcSEcCtD
Azilsartan medoxomil—Asthenia—Gabapentin—epilepsy syndrome	0.000793	0.00137	CcSEcCtD
Azilsartan medoxomil—Nausea—Valproic Acid—epilepsy syndrome	0.000792	0.00137	CcSEcCtD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—GABBR1—epilepsy syndrome	0.000783	0.00192	CbGpPWpGaD
Azilsartan medoxomil—Pruritus—Gabapentin—epilepsy syndrome	0.000782	0.00136	CcSEcCtD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCR2—epilepsy syndrome	0.00078	0.00191	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—SST—epilepsy syndrome	0.00078	0.00191	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—SSTR4—epilepsy syndrome	0.000765	0.00188	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—SSTR5—epilepsy syndrome	0.000765	0.00188	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—ADRA2A—epilepsy syndrome	0.000763	0.00187	CbGpPWpGaD
Azilsartan medoxomil—Rash—Pregabalin—epilepsy syndrome	0.00076	0.00132	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Pregabalin—epilepsy syndrome	0.000759	0.00132	CcSEcCtD
Azilsartan medoxomil—Diarrhoea—Gabapentin—epilepsy syndrome	0.000756	0.00131	CcSEcCtD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—HRH3—epilepsy syndrome	0.000751	0.00184	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Peptide ligand-binding receptors—CCR5—epilepsy syndrome	0.000749	0.00184	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—G alpha (q) signalling events—HTR2A—epilepsy syndrome	0.000742	0.00182	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Allograft Rejection—VEGFA—epilepsy syndrome	0.000742	0.00182	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—OPRM1—epilepsy syndrome	0.000739	0.00182	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—CCR10—epilepsy syndrome	0.000734	0.0018	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCL12—epilepsy syndrome	0.000733	0.0018	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—BDKRB2—epilepsy syndrome	0.000733	0.0018	CbGpPWpGaD
Azilsartan medoxomil—Dizziness—Gabapentin—epilepsy syndrome	0.000731	0.00127	CcSEcCtD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—CNR1—epilepsy syndrome	0.000719	0.00177	CbGpPWpGaD
Azilsartan medoxomil—Nausea—Pregabalin—epilepsy syndrome	0.000716	0.00124	CcSEcCtD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—GRM2—epilepsy syndrome	0.000706	0.00173	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—G alpha (q) signalling events—AGT—epilepsy syndrome	0.000704	0.00173	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—HTR7—epilepsy syndrome	0.000702	0.00172	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—CCR3—epilepsy syndrome	0.000698	0.00171	CbGpPWpGaD
Azilsartan medoxomil—Rash—Gabapentin—epilepsy syndrome	0.000697	0.00121	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Gabapentin—epilepsy syndrome	0.000696	0.00121	CcSEcCtD
Azilsartan medoxomil—AGTR1—Peptide ligand-binding receptors—AGT—epilepsy syndrome	0.000695	0.00171	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Angiopoietin receptor Tie2-mediated signaling—AKT1—epilepsy syndrome	0.000683	0.00168	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—NPY—epilepsy syndrome	0.00068	0.00167	CbGpPWpGaD
Azilsartan medoxomil—Asthenia—Topiramate—epilepsy syndrome	0.000667	0.00116	CcSEcCtD
Azilsartan medoxomil—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—epilepsy syndrome	0.000664	0.00163	CbGpPWpGaD
Azilsartan medoxomil—Pruritus—Topiramate—epilepsy syndrome	0.000658	0.00114	CcSEcCtD
Azilsartan medoxomil—Nausea—Gabapentin—epilepsy syndrome	0.000657	0.00114	CcSEcCtD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—CXCL2—epilepsy syndrome	0.000656	0.00161	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—CRH—epilepsy syndrome	0.000656	0.00161	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—CCL3—epilepsy syndrome	0.000656	0.00161	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—OXT—epilepsy syndrome	0.000656	0.00161	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—GRM2—epilepsy syndrome	0.000641	0.00157	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—SSTR3—epilepsy syndrome	0.000639	0.00157	CbGpPWpGaD
Azilsartan medoxomil—Diarrhoea—Topiramate—epilepsy syndrome	0.000636	0.0011	CcSEcCtD
Azilsartan medoxomil—AGTR1—Allograft Rejection—TNF—epilepsy syndrome	0.000636	0.00156	CbGpPWpGaD
Azilsartan medoxomil—Losartan—ALB—epilepsy syndrome	0.000634	0.0398	CrCbGaD
Azilsartan medoxomil—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—epilepsy syndrome	0.00063	0.00155	CbGpPWpGaD
Azilsartan medoxomil—Dizziness—Topiramate—epilepsy syndrome	0.000615	0.00107	CcSEcCtD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—SSTR1—epilepsy syndrome	0.000612	0.0015	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—ARHGEF9—epilepsy syndrome	0.000612	0.0015	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—CCR8—epilepsy syndrome	0.000612	0.0015	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—CCR9—epilepsy syndrome	0.000612	0.0015	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—NPY2R—epilepsy syndrome	0.000612	0.0015	CbGpPWpGaD
Azilsartan medoxomil—Losartan—ABCB1—epilepsy syndrome	0.000605	0.038	CrCbGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—GRM4—epilepsy syndrome	0.0006	0.00147	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—GRM3—epilepsy syndrome	0.0006	0.00147	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—CCR2—epilepsy syndrome	0.000594	0.00146	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—SST—epilepsy syndrome	0.000594	0.00146	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—AVP—epilepsy syndrome	0.000591	0.00145	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—SSTR2—epilepsy syndrome	0.000589	0.00145	CbGpPWpGaD
Azilsartan medoxomil—Rash—Topiramate—epilepsy syndrome	0.000586	0.00102	CcSEcCtD
Azilsartan medoxomil—AGTR1—GPCRs, Class A Rhodopsin-like—CCR5—epilepsy syndrome	0.000586	0.00144	CbGpPWpGaD
Azilsartan medoxomil—Dermatitis—Topiramate—epilepsy syndrome	0.000586	0.00102	CcSEcCtD
Azilsartan medoxomil—AGTR1—Peptide ligand-binding receptors—POMC—epilepsy syndrome	0.000585	0.00144	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—ADRA2A—epilepsy syndrome	0.000581	0.00143	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—SSTR3—epilepsy syndrome	0.00058	0.00142	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6ST—epilepsy syndrome	0.00058	0.00142	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCRs, Class A Rhodopsin-like—HTR2A—epilepsy syndrome	0.000574	0.00141	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Peptide ligand-binding receptors—CCL2—epilepsy syndrome	0.000573	0.00141	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—PRDM4—epilepsy syndrome	0.000572	0.0014	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—PRICKLE1—epilepsy syndrome	0.000572	0.0014	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—GRM8—epilepsy syndrome	0.000569	0.0014	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—CXCL12—epilepsy syndrome	0.000558	0.00137	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—BDKRB2—epilepsy syndrome	0.000558	0.00137	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—ARHGEF9—epilepsy syndrome	0.000556	0.00137	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—NPY2R—epilepsy syndrome	0.000556	0.00137	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—CCR9—epilepsy syndrome	0.000556	0.00137	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—SSTR1—epilepsy syndrome	0.000556	0.00137	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—CCR8—epilepsy syndrome	0.000556	0.00137	CbGpPWpGaD
Azilsartan medoxomil—Nausea—Topiramate—epilepsy syndrome	0.000552	0.000958	CcSEcCtD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—CNR1—epilepsy syndrome	0.000548	0.00135	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—GRM4—epilepsy syndrome	0.000545	0.00134	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—GRM3—epilepsy syndrome	0.000545	0.00134	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—OPRD1—epilepsy syndrome	0.000543	0.00133	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—SSTR2—epilepsy syndrome	0.000535	0.00131	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—HTR7—epilepsy syndrome	0.000535	0.00131	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—GRM1—epilepsy syndrome	0.000521	0.00128	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—CCR7—epilepsy syndrome	0.000521	0.00128	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—CHRM1—epilepsy syndrome	0.000521	0.00128	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—PDYN—epilepsy syndrome	0.000521	0.00128	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—GRM8—epilepsy syndrome	0.000517	0.00127	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCR5—epilepsy syndrome	0.000502	0.00123	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—ACKR4—epilepsy syndrome	0.0005	0.00123	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—GNAO1—epilepsy syndrome	0.000493	0.00121	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—OPRD1—epilepsy syndrome	0.000493	0.00121	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—HTR2A—epilepsy syndrome	0.000492	0.00121	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—GAL—epilepsy syndrome	0.000489	0.0012	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—GRM5—epilepsy syndrome	0.000484	0.00119	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—CHRM3—epilepsy syndrome	0.000484	0.00119	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—GRM1—epilepsy syndrome	0.000473	0.00116	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—CHRM1—epilepsy syndrome	0.000473	0.00116	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—CCR7—epilepsy syndrome	0.000473	0.00116	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—PDYN—epilepsy syndrome	0.000473	0.00116	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—AGT—epilepsy syndrome	0.000466	0.00115	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—BDKRB1—epilepsy syndrome	0.000455	0.00112	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—CHRM2—epilepsy syndrome	0.000455	0.00112	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—SSTR4—epilepsy syndrome	0.000452	0.00111	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—SSTR5—epilepsy syndrome	0.000452	0.00111	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—AVP—epilepsy syndrome	0.00045	0.0011	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—GAL—epilepsy syndrome	0.000444	0.00109	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—GABBR1—epilepsy syndrome	0.000443	0.00109	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—GRM5—epilepsy syndrome	0.00044	0.00108	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—CHRM3—epilepsy syndrome	0.00044	0.00108	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CCR10—epilepsy syndrome	0.000433	0.00106	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—HRH3—epilepsy syndrome	0.000424	0.00104	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—CX3CR1—epilepsy syndrome	0.000421	0.00103	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—OPRM1—epilepsy syndrome	0.000418	0.00103	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—BDKRB1—epilepsy syndrome	0.000413	0.00101	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—CX3CL1—epilepsy syndrome	0.000413	0.00101	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—CHRM2—epilepsy syndrome	0.000413	0.00101	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—GABBR1—epilepsy syndrome	0.000402	0.000987	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—CCR3—epilepsy syndrome	0.000395	0.000969	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—POMC—epilepsy syndrome	0.000393	0.000964	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—HRH3—epilepsy syndrome	0.000385	0.000947	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—NPY—epilepsy syndrome	0.000384	0.000944	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCL2—epilepsy syndrome	0.000384	0.000943	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—CCR5—epilepsy syndrome	0.000383	0.000939	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—OPRM1—epilepsy syndrome	0.000379	0.000932	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—GRM2—epilepsy syndrome	0.000379	0.00093	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—HTR2A—epilepsy syndrome	0.000374	0.000919	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—CXCL2—epilepsy syndrome	0.000371	0.000911	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—CRH—epilepsy syndrome	0.000371	0.000911	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—OXT—epilepsy syndrome	0.000371	0.000911	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—CCR3—epilepsy syndrome	0.000358	0.00088	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—AGT—epilepsy syndrome	0.000355	0.000872	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—NPY—epilepsy syndrome	0.000349	0.000858	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—SSTR3—epilepsy syndrome	0.000343	0.000841	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—CXCL2—epilepsy syndrome	0.000337	0.000827	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—OXT—epilepsy syndrome	0.000337	0.000827	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—CRH—epilepsy syndrome	0.000337	0.000827	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—CCL3—epilepsy syndrome	0.000337	0.000827	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—SST—epilepsy syndrome	0.000335	0.000824	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—CCR2—epilepsy syndrome	0.000335	0.000824	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—ST3GAL3—epilepsy syndrome	0.000335	0.000823	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CCR9—epilepsy syndrome	0.000328	0.000807	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—SSTR1—epilepsy syndrome	0.000328	0.000807	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—ARHGEF9—epilepsy syndrome	0.000328	0.000807	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CCR8—epilepsy syndrome	0.000328	0.000807	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—NPY2R—epilepsy syndrome	0.000328	0.000807	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—ADRA2A—epilepsy syndrome	0.000328	0.000806	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—GRM3—epilepsy syndrome	0.000322	0.000791	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—GRM4—epilepsy syndrome	0.000322	0.000791	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—DUSP4—epilepsy syndrome	0.000316	0.000776	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—SSTR2—epilepsy syndrome	0.000316	0.000776	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—CXCL12—epilepsy syndrome	0.000315	0.000775	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—BDKRB2—epilepsy syndrome	0.000315	0.000775	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—CNR1—epilepsy syndrome	0.00031	0.00076	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—PLCB1—epilepsy syndrome	0.000308	0.000758	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—GRM8—epilepsy syndrome	0.000305	0.00075	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—PGF—epilepsy syndrome	0.000305	0.00075	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—CCR2—epilepsy syndrome	0.000305	0.000748	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—SST—epilepsy syndrome	0.000305	0.000748	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—HTR7—epilepsy syndrome	0.000302	0.000742	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—POMC—epilepsy syndrome	0.000299	0.000734	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—ADRA2A—epilepsy syndrome	0.000298	0.000732	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—CCL2—epilepsy syndrome	0.000293	0.000718	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—OPRD1—epilepsy syndrome	0.000291	0.000715	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—GNAO1—epilepsy syndrome	0.000291	0.000715	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—AKT3—epilepsy syndrome	0.000288	0.000707	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—CXCL12—epilepsy syndrome	0.000286	0.000703	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—BDKRB2—epilepsy syndrome	0.000286	0.000703	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—CNR1—epilepsy syndrome	0.000281	0.00069	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—PLCB1—epilepsy syndrome	0.00028	0.000688	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CHRM1—epilepsy syndrome	0.000279	0.000686	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—PDYN—epilepsy syndrome	0.000279	0.000686	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CCR7—epilepsy syndrome	0.000279	0.000686	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—GRM1—epilepsy syndrome	0.000279	0.000686	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—HTR7—epilepsy syndrome	0.000274	0.000674	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—HBEGF—epilepsy syndrome	0.000266	0.000654	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—CDC42—epilepsy syndrome	0.000263	0.000645	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—GAL—epilepsy syndrome	0.000263	0.000645	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—GFAP—epilepsy syndrome	0.000263	0.000645	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—AKT3—epilepsy syndrome	0.000261	0.000642	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CHRM3—epilepsy syndrome	0.00026	0.000638	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—GRM5—epilepsy syndrome	0.00026	0.000638	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CASP2—epilepsy syndrome	0.00026	0.000638	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—AVP—epilepsy syndrome	0.000254	0.000624	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CX3CR1—epilepsy syndrome	0.000249	0.000611	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—BDKRB1—epilepsy syndrome	0.000244	0.0006	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CHRM2—epilepsy syndrome	0.000244	0.0006	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CX3CL1—epilepsy syndrome	0.000244	0.0006	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—CDC42—epilepsy syndrome	0.000238	0.000586	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—GABBR1—epilepsy syndrome	0.000237	0.000583	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—AVP—epilepsy syndrome	0.000231	0.000567	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—HRH3—epilepsy syndrome	0.000228	0.000559	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—OPRM1—epilepsy syndrome	0.000224	0.00055	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—CCR5—epilepsy syndrome	0.000216	0.000531	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CCR3—epilepsy syndrome	0.000212	0.00052	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—HTR2A—epilepsy syndrome	0.000212	0.00052	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—NPY—epilepsy syndrome	0.000206	0.000507	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—ATP2A2—epilepsy syndrome	0.000206	0.000507	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—AGT—epilepsy syndrome	0.000201	0.000493	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CRH—epilepsy syndrome	0.000199	0.000489	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—OXT—epilepsy syndrome	0.000199	0.000489	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CXCL2—epilepsy syndrome	0.000199	0.000489	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CCL3—epilepsy syndrome	0.000199	0.000489	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—HSPB1—epilepsy syndrome	0.000199	0.000489	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—CCR5—epilepsy syndrome	0.000196	0.000482	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—HTR2A—epilepsy syndrome	0.000192	0.000472	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—PRKCB—epilepsy syndrome	0.000185	0.000456	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—TSC1—epilepsy syndrome	0.000185	0.000454	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—PTK2B—epilepsy syndrome	0.000185	0.000454	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—AGT—epilepsy syndrome	0.000182	0.000448	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CCR2—epilepsy syndrome	0.00018	0.000442	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—NTRK2—epilepsy syndrome	0.00018	0.000442	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—SST—epilepsy syndrome	0.00018	0.000442	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—DUSP6—epilepsy syndrome	0.000178	0.000438	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—ADRA2A—epilepsy syndrome	0.000176	0.000433	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—PLAT—epilepsy syndrome	0.000175	0.000431	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—BDKRB2—epilepsy syndrome	0.000169	0.000416	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CXCL12—epilepsy syndrome	0.000169	0.000416	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—POMC—epilepsy syndrome	0.000169	0.000415	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—PRKCB—epilepsy syndrome	0.000168	0.000414	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—IL6ST—epilepsy syndrome	0.000168	0.000412	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—JUNB—epilepsy syndrome	0.000166	0.000408	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CNR1—epilepsy syndrome	0.000166	0.000408	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—PLCB1—epilepsy syndrome	0.000165	0.000406	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—HTR7—epilepsy syndrome	0.000162	0.000398	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—HBEGF—epilepsy syndrome	0.000157	0.000386	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—AKT3—epilepsy syndrome	0.000154	0.000379	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—POMC—epilepsy syndrome	0.000153	0.000377	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—ADAM10—epilepsy syndrome	0.000151	0.00037	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—CCL2—epilepsy syndrome	0.00015	0.000369	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—S100B—epilepsy syndrome	0.000143	0.00035	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—SOCS3—epilepsy syndrome	0.000141	0.000347	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CDC42—epilepsy syndrome	0.000141	0.000346	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—AVP—epilepsy syndrome	0.000136	0.000335	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—HES1—epilepsy syndrome	0.000129	0.000317	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—FYN—epilepsy syndrome	0.000125	0.000308	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—H2AFX—epilepsy syndrome	0.000125	0.000307	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—MEF2C—epilepsy syndrome	0.000125	0.000306	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—YWHAZ—epilepsy syndrome	0.000121	0.000296	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—NGF—epilepsy syndrome	0.000119	0.000293	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CCR5—epilepsy syndrome	0.000116	0.000285	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—HTR2A—epilepsy syndrome	0.000113	0.000279	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—TSC2—epilepsy syndrome	0.000108	0.000265	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—AGT—epilepsy syndrome	0.000108	0.000264	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—APOE—epilepsy syndrome	0.000106	0.000259	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—KDR—epilepsy syndrome	0.000103	0.000254	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—PRKCB—epilepsy syndrome	9.95e-05	0.000244	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—IL6ST—epilepsy syndrome	9.91e-05	0.000243	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—POMC—epilepsy syndrome	9.06e-05	0.000223	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CCL2—epilepsy syndrome	8.87e-05	0.000218	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—FGF2—epilepsy syndrome	8.01e-05	0.000197	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—RELA—epilepsy syndrome	7.44e-05	0.000183	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—MTOR—epilepsy syndrome	7.3e-05	0.000179	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—AKT1—epilepsy syndrome	6.77e-05	0.000166	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CASP3—epilepsy syndrome	6.71e-05	0.000165	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—JUN—epilepsy syndrome	6.52e-05	0.00016	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—MMP9—epilepsy syndrome	6.34e-05	0.000156	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—AKT1—epilepsy syndrome	6.15e-05	0.000151	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—SRC—epilepsy syndrome	5.85e-05	0.000144	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—VEGFA—epilepsy syndrome	5.69e-05	0.00014	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—AKT1—epilepsy syndrome	3.63e-05	8.92e-05	CbGpPWpGaD
